Halozyme Therapeutics, Inc. Logo Image

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. Banner Image

Halozyme Therapeutics, Inc. has reached its limit for report views.

Please check back to see if Halozyme Therapeutics, Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2015 Annual Report and Form 10K

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Halozyme Therapeutics, Inc.

201-500 Employees
Based in San Diego, California

Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.

Ticker:
HALO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol